AstraZeneca (AZ) has entered into an exclusive licence agreement worth over $1.9bn to advance CSPC Pharmaceutical Group’s pre ...

Chiesi Group has announced the operational launch of its biotech centre of excellence in Italy. The company has invested ...

Hospitals engaging in industry partnerships were found to be up to 2.5 times more likely to follow NICE guidelines ...

Bristol Myers Squibb’s Opdivo (nivolumab) has been approved by the US Food and Drug Administration (FDA) as part of a ...

Like most people these days, I have been experimenting with various artificial intelligence (AI) tools this past year. It’s ...

One of the candidates included in the deal has already shown promise in a phase 1a advanced breast cancer study ...

The US Food and Drug Administration (FDA) has approved IntraBio’s Aqneursa (levacetylleucine) to treat neurological symptoms ...

Diversity and inclusion are critical to business success, particularly when fostering innovation and creativity. At Mednet, ...

Rock Unlimited: Solid science. Fluid thinking. Lasting change.

Torpedo Group Torpedo is where great ideas come to life. We’re a creative agency for the digital world, blending insight, ideas and technology to deliver multi-channel marketing programs that engage ...

Bristol Myers Squibb (BMS) has announced positive results from a phase 3b/4 study of its oral TYK2 inhibitor Sotyktu (deucravacitinib) in moderate-to-severe scalp psoriasis. Data from the ongoing ...